Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

stavudine

A synthetic nucleoside, analog of didehydro-3-deoxythymidine with potent antiretroviral activity. In vivo, stavudine is phosphorylated by cellular kinases to the active metabolite stavudine triphosphate; this metabolite inhibits the activity of HIV reverse transcriptase both by competing with the natural substrate deoxythymidine triphosphate and by incorporation into viral DNA causing a termination of DNA chain elongation (due to the lack the essential 3'-OH group).
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:didehydrodeoxythymidine
dideoxydidehydrothymidine
US brand name:Zerit
Abbreviation:d4T
Code name:BMY-27857
Chemical structure:1-(2,3-dideoxy-beta-glycero-pent-2-enofuranosyl)thymine
2',3'-didehydro-3'-deoxythymidine
3'-deoxy-2'-thymidinene
NSC code:163661
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search